Skip to main content
. 2017 May 23;108(6):1271–1280. doi: 10.1111/cas.13249

Figure 4.

Figure 4

Overall survival of patients with diffuse large B‐cell lymphoma‐type or classical Hodgkin lymphoma‐type methotrexate‐associated lymphoproliferative disorders. The difference in overall survival was not statistically significant (P = 0.408).